Article Sidebar

Download
PDF
Statistic
Read Counter : 231 Download : 276

Main Article Content

Abstract

Background: This review deals with a collection of information about a protein marker that is very important and alternates presence in many cases of normal and pathological growth, as it can be observed in high concentrations in the stages of fetal development and can be expressed significantly in many cases and disorders and midkine is considered a diagnostic marker for them as in types of cancers. It has a protein structure of 121 amino acids and its expression is located on the eleventh chromosome and has several functions, especially its expression in nervous tissues during the mid-gestation.


Conclusion: Midkine plays an important role in the inflammatory process in terms of its importance in the infiltration of immune cells into the peripheral organs and targeting midkine may be a viable new therapeutic option for chronic infections, especially infections of the kidneys, joints, nervous system and colon.

Keywords

Midkine, Neurogenesis, Therapeutic, Chronic Inflammation

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
M. Jawad, M. ., & H. Hussein, A. . (2022). A Review Of Midkine As Biomarker Protein For Diagnostic Several Dieases. Medical Science Journal for Advance Research, 3(2), 61–68. https://doi.org/10.46966/msjar.v3i2.42
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. • Cai, Y., Lv, Y., Mo, Z., Lei, J., Zhu, J., & Zhong, Q. (2020). Multiple pathophysiological roles of midkine in human disease. Cytokine, 135(April), 155242. https://doi.org/10.1016/j.cyto.2020.155242
  2. • Campbell, V. K., Gately, R. P., Krishnasamy, R., Burg, D., Robertson, G. R., & Gray, N. A. (2021). Midkine and chronic kidney disease-associated multisystem organ dysfunctions. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 36(9), 1577–1584. https://doi.org/10.1093/ndt/gfaa084
  3. • Chang, W., Peng, F., Sun, Q., Meng, S.-S., Qiu, H.-B., & Xu, J.-Y. (2020). Plasma Midkine Is Associated With 28-Day Mortality and Organ Function in Sepsis. Journal of Intensive Care Medicine, 35(11), 1290–1296. https://doi.org/10.1177/0885066619861580
  4. • Cheng, Y.-P., Lin, C., Lin, P.-Y., Cheng, C.-Y., Ma, H.-I., Chen, C.-M., & Hueng, D.-Y. (2014). Midkine expression in high grade gliomas: Correlation of this novel marker with proliferation and survival in human gliomas. Surgical Neurology International, 5(1), 78. https://doi.org/10.4103/2152-7806.133205
  5. • Gowhari Shabgah, A., Ezzatifar, F., Aravindhan, S., Olegovna Zekiy, A., Ahmadi, M., Gheibihayat, S. M., & Gholizadeh Navashenaq, J. (2021). Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB Life, 73(4), 659–669. https://doi.org/10.1002/iub.2458
  6. • Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018). Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Research, 6(1), 15. https://doi.org/10.1038/s41413-018-0016-9
  7. • Hadida, W. M., Ali, D. A., ELnemr, A. A., & Nofal, H. E. (2019). The Role of Midkine in Breast Cancer. The Egyptian Journal of Hospital Medicine, 77(3), 5089–5095. https://doi.org/10.21608/ejhm.2019.49550
  8. • Ji, L., Gu, L., Zhang, X., & Wang, J. (2020). Evaluation of serum midkine and carcinoembryonic antigen as diagnostic biomarkers for rectal cancer and synchronous metastasis. Translational Cancer Research, 9(4), 2814–2823. https://doi.org/10.21037/tcr.2020.02.43
  9. • Vieceli Kekilli, M., Tanoğlu, A., Karaahmet, F., Doğan, Z., Can, M., Sayilir, A., Çakal, B., Düzenli, T., & Beyazit, Y. (2020). Midkine level may be used as a noninvasive biomarker in Crohn’s disease. Turkish Journal Of Medical Sciences, 44(2), 324–329. https://doi.org/10.3906/sag-1904-167
  10. • Kemper, M., Hentschel, W., Graß, J., Stüben, B., Konczalla, L., Rawnaq, T., Ghadban, T., Izbicki, J. R., & Reeh, M. (2020). Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival. Cancer Medicine, 9(6), 2010–2018. https://doi.org/10.1002/cam4.2884
  11. • Komata, Y., Tsubota, S., Sakamoto, K., Ikematsu, S., & Kadomatsu, K. (2021). Screening of novel Midkine binding protein by BioID2-based proximity labeling. Nagoya Journal of Medical Science, 83(3), 495–508. https://doi.org/10.18999/nagjms.83.3.495
  12. • Lassmann, H. (2018). Multiple Sclerosis Pathology. Cold Spring Harbor Perspectives in Medicine, 8(3), a028936. https://doi.org/10.1101/cshperspect.a028936
  13. • Mashaly, A. H., Anwar, R., Ebrahim, M. A., Eissa, L. A., & El Shishtawy, M. M. (2018). Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients. Asian Pacific Journal of Cancer Prevention : APJCP, 19(6), 1503–1508. https://doi.org/10.22034/APJCP.2018.19.6.1503
  14. • Metwalley, K. A., Farghaly, H. S., Gabri, M. F., Abdel-Aziz, S. M., Ismail, A. M., Raafat, D. M., & Elnakeeb, I. F. (2021). Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus. Journal of Clinical Research in Pediatric Endocrinology, 13(3),293–299. https://doi.org/10.4274/jcrpe.galenos.2021.2020.0303
  15. • Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020). Role of tau protein in Alzheimer’s disease: The prime pathological player. International Journal of Biological Macromolecules, 163(5), 1599–1617. https://doi.org/10.1016/j.ijbiomac.2020.07.327
  16. • Osman, O. S., Mohammed, E., Mahran, Z., Bakr, A., Mohareb, D., & Hakim Nasr, E. A.-E. (2018). Evaluation of serum Midkine as a novel biomarker for the diagnosis of hepatocellular carcinoma. Journal of Current Medical Research and Practice, 3(3), 154. https://doi.org/10.4103/JCMRP.JCMRP_153_18
  17. • PÜRNAK, S., KÜLCÜ ÇAKMAK, S., ÇAKIR, B., TURHAN, T., & ARTÜZ, F. (2020). Serum Midkine Levels in Patients with Psoriasis. Turkiye Klinikleri Journal of Dermatology, 30(1), 1–5. https://doi.org/10.5336/dermato.2019-71481
  18. • Rawnaq, T., Dietrich, L., Wolters-Eisfeld, G., Uzunoglu, F. G., Vashist, Y. K., Bachmann, K., Simon, R., Izbicki, J. R., Bockhorn, M., & Güngör, C. (2014). The Multifunctional Growth Factor Midkine Promotes Proliferation and Migration in Pancreatic Cancer. Molecular Cancer Research, 12(5), 670–680. https://doi.org/10.1158/1541-7786.MCR-13-0467
  19. • Ross-Munro, E., Kwa, F., Kreiner, J., Khore, M., Miller, S. L., Tolcos, M., Fleiss, B., & Walker, D. W. (2020). Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury. Frontiers in Neurology, 11(October), 1–22. https://doi.org/10.3389/fneur.2020.568814
  20. • Said, E. A., Al-Dughaishi, S., Al-Hatmi, W., Al-Reesi, I., Al-Riyami, M., Al-Balushi, M. S., Al-Bimani, A., Al-Busaidi, J. Z., Al-Khabori, M., Al-Kindi, S., Procopio, F. A., Al-Rashdi, A., Al-Ansari, A., Babiker, H., Koh, C. Y., Al-Naamani, K., Pantaleo, G., & Al-Jabri, A. A. (2022). Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production. PLOS ONE, 17(4), e0267662. https://doi.org/10.1371/journal.pone.0267662
  21. • Shindo, E., Nanki, T., Kusunoki, N., Shikano, K., Kawazoe, M., Sato, H., Kaneko, K., Muraoka, S., Kaburaki, M., Akasaka, Y., Shimada, H., Hasunuma, T., & Kawai, S. (2017). The growth factor midkine may play a pathophysiological role in rheumatoid arthritis. Modern Rheumatology, 27(1), 54–59. https://doi.org/10.1080/14397595.2016.1179860
  22. • Tontini, G. E. (2015). Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World Journal of Gastroenterology, 21(1), 21. https://doi.org/10.3748/wjg.v21.i1.21
  23. • Tsai, S. L., Baselga-Garriga, C., & Melton, D. A. (2020). Midkine is a dual regulator of wound epidermis development and inflammation during the initiation of limb regeneration. ELife, 9(7), 1–29. https://doi.org/10.7554/eLife.50765
  24. • Vu Van, D., Heberling, U., Wirth, M. P., & Fuessel, S. (2016). Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer. Oncology Letters, 12(5), 3143–3152. https://doi.org/10.3892/ol.2016.5040
  25. • Wang, J., Lewis, J. R., Byrnes, E., Wong, G., Raymond, W. D., Zhu, K., Robertson, G. R., Lim, W. H., Cao, Q., Prince, R. L., & Lee, V. W. (2020). Serum Midkine, estimated glomerular filtration rate and chronic kidney disease-related events in elderly women: Perth Longitudinal Study of Aging Women. Scientific Reports, 10(1), 14499. https://doi.org/10.1038/s41598-020-71353-8
  26. • Weckbach, L., Preissner, K., & Deindl, E. (2018). The Role of Midkine in Arteriogenesis, Involving Mechanosensing, Endothelial Cell Proliferation, and Vasodilation. International Journal of Molecular Sciences, 19(9), 2559. https://doi.org/10.3390/ijms19092559
  27. • Wu, X., Zhi, X., Ji, M., Wang, Q., Li, Y., Xie, J., & Zhao, S. (2015). Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy. American Journal of Cancer Research, 5(2), 629–638. http://www.ncbi.nlm.nih.gov/pubmed/25973302%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4396029
  28. • Xia, X., Lu, J.-J., Zhang, S.-S., Su, C.-H., & Luo, H.-H. (2016). Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer. Oncotarget, 7(52), 87462–87472. https://doi.org/10.18632/oncotarget.13865
  29. • Yamauchi, K. (2016). Thyroid Hormones. In Handbook of Hormones (pp. 493-e93-2). Elsevier. https://doi.org/10.1016/B978-0-12-801028-0.00093-3
  30. • Zhang, D., Ding, L., Li, Y., Ren, J., Shi, G., Wang, Y., Zhao, S., Ni, Y., & Hou, Y. (2017). Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells. Scientific Reports, 7(1), 16231. https://doi.org/10.1038/s41598-017-13431-y
  31. • Zhang, Y., Chen, Y., Huang, H., Sandler, J., Dai, M., Ma, S., & Udelsman, R. (2015). Diagnostic radiography exposure increases the risk for thyroid microcarcinoma. European Journal of Cancer Prevention, 24(5), 439–446. https://doi.org/10.1097/CEJ.0000000000000169
  32. • Zhang, Z.-Z., Wang, G., Yin, S.-H., & Yu, X.-H. (2021). Midkine: A multifaceted driver of atherosclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry, 521(July), 251–257. https://doi.org/10.1016/j.cca.2021.07.024
  33. • Zhou, L., Jiang, J., Fu, Y., Zhang, D., Li, T., Fu, Q., Yan, C., Zhong, Y., Dionigi, G., Liang, N., & Sun, H. (2021). Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules. Diagnostic Pathology, 16(1), 92. https://doi.org/10.1186/s13000-021-01150-y
  34. • Zou, B., Sun, L., Wang, X., & Chen, Z. (2020). The Prevalence of Single and Multiple Thyroid Nodules and Its Association with Metabolic Diseases in Chinese: A Cross-Sectional Study. International Journal of Endocrinology, 2020(3), 1–11.
  35. https://doi.org/10.1155/2020/5381012